JP2021526552A5 - - Google Patents
Info
- Publication number
- JP2021526552A5 JP2021526552A5 JP2021515298A JP2021515298A JP2021526552A5 JP 2021526552 A5 JP2021526552 A5 JP 2021526552A5 JP 2021515298 A JP2021515298 A JP 2021515298A JP 2021515298 A JP2021515298 A JP 2021515298A JP 2021526552 A5 JP2021526552 A5 JP 2021526552A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- pharmaceutical composition
- composition according
- compound
- group
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20180714 | 2018-05-23 | ||
| NO20180714 | 2018-05-23 | ||
| PCT/IB2019/000655 WO2019224602A2 (en) | 2018-05-23 | 2019-05-22 | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021526552A JP2021526552A (ja) | 2021-10-07 |
| JPWO2019224602A5 JPWO2019224602A5 (https=) | 2022-05-30 |
| JP2021526552A5 true JP2021526552A5 (https=) | 2022-05-30 |
| JP7508447B2 JP7508447B2 (ja) | 2024-07-01 |
Family
ID=67688797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021515298A Active JP7508447B2 (ja) | 2018-05-23 | 2019-05-22 | 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210290576A1 (https=) |
| EP (1) | EP3796901A2 (https=) |
| JP (1) | JP7508447B2 (https=) |
| KR (2) | KR20250150676A (https=) |
| CN (1) | CN112351775A (https=) |
| AU (1) | AU2019274203B2 (https=) |
| CA (1) | CA3101041A1 (https=) |
| WO (1) | WO2019224602A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102760537B1 (ko) | 2022-01-20 | 2025-02-03 | 한국과학기술연구원 | 삼원계 광활성층 조성물 및 이를 포함하는 유기태양전지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5620272B2 (ja) | 2007-11-09 | 2014-11-05 | プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ ＮｏｒｇｅＡＳ | 化粧品において，食品サプリメントとして，または医薬品として用いるための脂質化合物 |
| EP2147910A1 (en) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
| SG175401A1 (en) * | 2009-05-08 | 2011-12-29 | Pronova Biopharma Norge As | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| JP2013517322A (ja) | 2010-01-20 | 2013-05-16 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | サリチレート脂肪酸誘導体 |
| CA3070513C (en) * | 2010-05-05 | 2023-01-03 | Boehringer Ingelheim International Gmbh | A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis |
| PL2961727T3 (pl) | 2013-02-28 | 2017-06-30 | Pronova Biopharma Norge As | Sposób wytwarzania kwasu 2-((5Z,8Z, 11Z,14Z,17Z)-ejkoza-5,8,11,14,17-pentaenyloksy)butanowego |
| US20180110747A1 (en) | 2015-04-01 | 2018-04-26 | Pronova Biopharma Norge As | Use of thia oxo compounds for lowering apo c3 |
| BR112017023164A2 (en) * | 2015-04-28 | 2018-07-24 | Pronova Biopharma Norge As | and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof |
-
2019
- 2019-05-22 JP JP2021515298A patent/JP7508447B2/ja active Active
- 2019-05-22 EP EP19756232.5A patent/EP3796901A2/en not_active Withdrawn
- 2019-05-22 KR KR1020257032515A patent/KR20250150676A/ko active Pending
- 2019-05-22 AU AU2019274203A patent/AU2019274203B2/en active Active
- 2019-05-22 WO PCT/IB2019/000655 patent/WO2019224602A2/en not_active Ceased
- 2019-05-22 US US17/057,204 patent/US20210290576A1/en not_active Abandoned
- 2019-05-22 KR KR1020207037063A patent/KR20210015883A/ko not_active Ceased
- 2019-05-22 CA CA3101041A patent/CA3101041A1/en active Pending
- 2019-05-22 CN CN201980034666.XA patent/CN112351775A/zh active Pending
-
2025
- 2025-06-05 US US19/229,520 patent/US20260000632A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528350A5 (https=) | ||
| US12129247B2 (en) | Administration regime for nitrocatechols | |
| JP2009530398A5 (https=) | ||
| JP2012097105A5 (https=) | ||
| EA201170193A1 (ru) | Новые содержащие серу липиды для применения в качестве пищевой добавки или в качестве лекарственного средства | |
| JP2019501133A5 (https=) | ||
| JP2016511753A5 (https=) | ||
| JP2004531543A5 (https=) | ||
| EA201171371A1 (ru) | Полиненасыщенные жирные кислоты для лечения заболеваний, связанных с сердечно-сосудистыми, метаболическими и воспалительными заболеваниями | |
| CN110105200A (zh) | 用于治疗纤维化的经取代的芳族化合物及相关方法 | |
| US20240166613A1 (en) | Proxisome proliferator activated receptor (ppar) compounds and methods of using the same | |
| KR20190020170A (ko) | 통풍 또는 고뇨산혈증과 관련된 증상의 치료 또는 예방을 위한 화합물, 조성물 및 방법 | |
| JP6647278B2 (ja) | 化合物 | |
| JP2023116579A (ja) | 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用 | |
| JP4553166B2 (ja) | ニコチン酸エステルおよびそれを含む薬剤組成物 | |
| JP2015519322A5 (https=) | ||
| US20230321022A1 (en) | Reversibly protected thiolated electrophilic fatty acids as prodrugs | |
| RU2017121460A (ru) | Производные пиридинкарбоксамида, способ их получения и их фармацевтическое применение | |
| JP5575651B2 (ja) | 新規のｄｈａ誘導体およびその医薬品としての用途 | |
| JP2016519106A5 (https=) | ||
| JP2015531376A5 (https=) | ||
| RU2013107759A (ru) | Производные оксадиазола и пиридазина, их получение и применение в терапии | |
| JP2021526552A5 (https=) | ||
| JP2024122966A (ja) | 芳香族化合物およびその医薬用途 | |
| JOP20230072A1 (ar) | تحضير مشتقات بنزيميدازولون كمثبطات داي أسيل جليسريد o -أسيل ترانسفيراز 2 جديدة |